The Effect of Early Substitution of Subclinical Hypothyroidism on Biochemical Blood Parameters and the Quality of Life

Overview

Journal J Med Biochem

Specialty Biochemistry

Date 2017 Jul 7

PMID 28680356

Citations 10

Authors

Milena S Pandrc

Andelka Ristic

Vanja Kostovski

Marko Stankovic

Vladimir Antic

Jelena Milin-Lazovic

Jasmina Ciric

Affiliations

Soon will be listed here.

Abstract

Background: Subclinical hypothyroidism (SCH) is defined as high TSH and normal thyroxine. Data on the effects of early substitution by levothyroxine on psychophysical health in SCH are still not consistent enough to support its introduction.

Methods: Clinical parameters, biochemical data and quality of life (Short Form 36 questionnaire) were measured before the intervention and 3 months after the euthyroid state had been achieved in SCH patients.

Results: Significant reduction in body weight (p=0.030), systolic and diastolic blood pressure (p=0.024, p=0.019), homocysteine (p<0.001), leukocytes and neutrophils (p=0.011, p=0.001), INR (p=0.049), K levels (p=0.040, p=0.013), HbA1c (p=0.001), fasting insulin (p<0.001) and insulin resistance measured by HOMA index (p<0.001), lipid parameters (total cholesterol (p<0.001), LDL-cholesterol (p<0.001), triglycerides (p=0.007), apoB (p=0.022), Lp(a) (p<0.001), LDL/HDL (p=0.008), LAP (p=0.04) and apoB/apoA1 ratios (p<0.023)), TSH (p<0.001) and tAbs (p<0.001) was recorded. Frequency of fatty liver (20% to 2.9%, p=0.016), hyperlipidemia (85% to 65.7%, p=0.001) and metabolic syndrome (34.3% to 2.9%, p=0.070) significantly decreased. A statistically significant positive association was found between the average dose of levothyroxine and changes in physical functioning (r=0.391, p=0.020), vitality (r=0.393, p=0.020), mental health (r=0.374, p=0.027) and overall dimensions of mental health (r=0.376, p=0.026). With increasing doses of levothyroxine, the previously listed scores of SF 36 grew (r=0.296, p=0.084).

Conclusions: Early substitution of SCH improved the many clinical and biochemical parameters related to cardiovascular risk. Quality of life was also improved, and correlated only with thyroxine doses suggesting an indirect relationship between the degree of hypothyroidism and quality of life.

Citing Articles

Association between Thyroid Hormones and Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis in Obese Individuals Undergoing Bariatric Surgery.

Ashraf Ganjooei N, Jamialahmadi T, Nematy M, Shah N, Jangjoo S, Emami N Middle East J Dig Dis. 2023; 14(4):410-421.

PMID: 37547501 PMC: 10404102. DOI: 10.34172/mejdd.2022.302.

[Hypothyroidism and aging: the search for protective factors].

Ilyushchenko A, Machekhina L, Dudinskaya E Probl Endokrinol (Mosk). 2023; 69(2):11-15.

PMID: 37448266 PMC: 10204782. DOI: 10.14341/probl13156.

Subclinical hypothyroidism has no association with insulin resistance indices in adult females: A case-control study.

Stoica R, Ancuceanu R, Costache A, Stefan S, Pantea Stoian A, Guja C Exp Ther Med. 2021; 22(3):1033.

PMID: 34373719 PMC: 8343699. DOI: 10.3892/etm.2021.10465.

Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options.

Tanase D, Gosav E, Neculae E, Costea C, Ciocoiu M, Hurjui L Int J Mol Sci. 2020; 21(16).

PMID: 32824723 PMC: 7460638. DOI: 10.3390/ijms21165927.

Correlation of Fgf23 and Balp with Bone Mineral Density in Hemodialysis Patients.

Bouksila M, Mrad M, Kaabachi W, Kalai E, Smaoui W, Rekik S J Med Biochem. 2019; 38(4):418-426.

PMID: 31496905 PMC: 6708290. DOI: 10.2478/jomb-2019-0002.

References

Waring A, Rodondi N, Harrison S, Kanaya A, Simonsick E, Miljkovic I . Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study. Clin Endocrinol (Oxf). 2011; 76(6):911-8. PMC: 3334430. DOI: 10.1111/j.1365-2265.2011.04328.x. View

Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg P, Lindstedt G . A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol (Oxf). 1988; 29(1):63-75. DOI: 10.1111/j.1365-2265.1988.tb00250.x. View

Monzani F, Del Guerra P, Caraccio N, Pruneti C, Pucci E, Luisi M . Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Investig. 1993; 71(5):367-71. DOI: 10.1007/BF00186625. View

Walsh J, Ward L, Burke V, Bhagat C, Shiels L, Henley D . Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: results of a double-blind, randomized clinical trial. J Clin Endocrinol Metab. 2006; 91(7):2624-30. DOI: 10.1210/jc.2006-0099. View

Andersen M, Olsen A, Madsen J, Faber J, Torp-Pedersen C, Gislason G . Levothyroxine Substitution in Patients with Subclinical Hypothyroidism and the Risk of Myocardial Infarction and Mortality. PLoS One. 2015; 10(6):e0129793. PMC: 4466400. DOI: 10.1371/journal.pone.0129793. View

Carr D, McLeod D, Parry G, Thornes H . Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endocrinol (Oxf). 1988; 28(3):325-33. DOI: 10.1111/j.1365-2265.1988.tb01219.x. View

Zhao M, Tang X, Yang T, Zhang B, Guan Q, Shao S . Lipotoxicity, a potential risk factor for the increasing prevalence of subclinical hypothyroidism?. J Clin Endocrinol Metab. 2015; 100(5):1887-94. DOI: 10.1210/jc.2014-3987. View

Lioudaki E, Mavroeidi N, Mikhailidis D, Ganotakis E . Subclinical hypothyroidism and vascular risk: an update. Hormones (Athens). 2014; 12(4):495-506. DOI: 10.14310/horm.2002.1437. View

Garduno-Garcia J, Alvirde-Garcia U, Lopez-Carrasco G, Padilla Mendoza M, Mehta R, Arellano-Campos O . TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol. 2010; 163(2):273-8. DOI: 10.1530/EJE-10-0312. View

10.

Karmisholt J, Andersen S, Laurberg P . Variation in thyroid function in subclinical hypothyroidism: importance of clinical follow-up and therapy. Eur J Endocrinol. 2011; 164(3):317-23. DOI: 10.1530/EJE-10-1021. View

11.

Pekmezovic T, Tepavcevic D, Kostic J, Drulovic J . Validation and cross-cultural adaptation of the disease-specific questionnaire MSQOL-54 in Serbian multiple sclerosis patients sample. Qual Life Res. 2007; 16(8):1383-7. DOI: 10.1007/s11136-007-9234-0. View

12.

Erdogan M, Canataroglu A, Ganidagli S, Kulaksizoglu M . Metabolic syndrome prevalence in subclinic and overt hypothyroid patients and the relation among metabolic syndrome parameters. J Endocrinol Invest. 2010; 34(7):488-92. DOI: 10.3275/7202. View

13.

Monzani F, Caraccio N, Kozakowa M, Dardano A, Vittone F, Virdis A . Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. J Clin Endocrinol Metab. 2004; 89(5):2099-106. DOI: 10.1210/jc.2003-031669. View

14.

Toft A, Beckett G . Thyroid function tests and hypothyroidism. BMJ. 2003; 326(7384):295-6. PMC: 1125169. DOI: 10.1136/bmj.326.7384.295. View

15.

Wang C, Chang T, Chen M . Associations between subclinical thyroid disease and metabolic syndrome. Endocr J. 2012; 59(10):911-7. DOI: 10.1507/endocrj.ej12-0076. View

16.

Park Y, Lee E, Lee Y, Choi S, Park J, Lee S . Subclinical hypothyroidism (SCH) is not associated with metabolic derangement, cognitive impairment, depression or poor quality of life (QoL) in elderly subjects. Arch Gerontol Geriatr. 2009; 50(3):e68-73. DOI: 10.1016/j.archger.2009.05.015. View

17.

Hennessey J, Espaillat R . Subclinical hypothyroidism: a historical view and shifting prevalence. Int J Clin Pract. 2015; 69(7):771-82. PMC: 6680332. DOI: 10.1111/ijcp.12619. View

18.

Pesic M, Radojkovic D, Antic S, Kocic R, Stankovic-Djordjevic D . Subclinical hypothyroidism: association with cardiovascular risk factors and components of metabolic syndrome. Biotechnol Biotechnol Equip. 2016; 29(1):157-163. PMC: 4684069. DOI: 10.1080/13102818.2014.991136. View

19.

Tuzcu A, Bahceci M, Gokalp D, Tuzun Y, Gunes K . Subclinical hypothyroidism may be associated with elevated high-sensitive c-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocr J. 2005; 52(1):89-94. DOI: 10.1507/endocrj.52.89. View

20.

Cooper D, Halpern R, WOOD L, Levin A, Ridgway E . L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med. 1984; 101(1):18-24. DOI: 10.7326/0003-4819-101-1-18. View